Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer

Cancer statistics for African American/Black People 2022

(2022) Angela N. Giaquinto et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The DNA methylome of cervical cells can predict the presence of ovarian cancer

(2022) James E. Barrett et al.   Nature Communications

Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer

(2022) Adrianna A. Mendes et al.   CANCER

Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes

(2021) Adam B. Weiner et al.   Nature Communications

Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1

(2021) Abigail K. Suwala et al.   ACTA NEUROPATHOLOGICA

Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup

(2021) Felix K. F. Kommoss et al.   MODERN PATHOLOGY

Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

(2021) Philipp Sievers et al.   ACTA NEUROPATHOLOGICA

Transcriptional landscape of PTEN loss in primary prostate cancer

(2021) Eddie Luidy Imada et al.   BMC CANCER

Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer

(2021) Harsimar B. Kaur et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

RNA expression differences in prostate tumors and tumor-adjacent stroma between Black and White Americans

(2021) Farah Rahmatpanah et al.   Oncotarget

Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences

(2021) Walter Rayford et al.   Communications Biology

Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors

(2021) Konrad H. Stopsack et al.   CLINICAL CANCER RESEARCH

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer

(2021) Janielle P Maynard et al.   JOURNAL OF PATHOLOGY

CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer

(2020) Farzana A Faisal et al.   CLINICAL CANCER RESEARCH

Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry

(2020) Jiao Yuan et al.   PLoS Genetics

Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians

(2020) Santosh Yadav et al.   ONCOGENE

Infratentorial IDH-mutant astrocytoma is a distinct subtype

(2020) Rouzbeh Banan et al.   ACTA NEUROPATHOLOGICA

Genomic Profiling of Prostate Cancers from Men with African and European Ancestry

(2020) Yusuke Koga et al.   CLINICAL CANCER RESEARCH

Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival

(2020) Yalei Chen et al.   BMC Medical Genomics

Comparative genomics reveals distinct immune-oncologic pathways in African American men with prostate cancer

(2020) Shivanshu Awasthi et al.   CLINICAL CANCER RESEARCH

Racial Differences in Genomic Profiling of Prostate Cancer

(2020) Brandon A. Mahal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Racial Disparities in Epigenetic Aging of the Right vs Left Colon

(2020) Matthew Devall et al.   JNCI-Journal of the National Cancer Institute

TP53 missense mutation is associated with increased tumor-infiltrating T-cells in primary prostate Cancer

(2019) Harsimar B. Kaur et al.   HUMAN PATHOLOGY

Aneuploidy drives lethal progression in prostate cancer

(2019) Konrad H. Stopsack et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells

(2019) Thiago Vidotto et al.   PROSTATE

Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis

(2019) Miller Huang et al.   Cell Stem Cell

Critical evaluation of copy number variant calling methods using DNA methylation

(2019) Varun Kilaru et al.   GENETIC EPIDEMIOLOGY

Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities

(2019) Annekathrin Reinhardt et al.   Acta Neuropathologica Communications

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

(2018) Alison M. Taylor et al.   CANCER CELL

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer

(2018) Harsimar B. Kaur et al.   MODERN PATHOLOGY

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer

(2018) Benjamin L. Maughan et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Whole Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naive, High-Risk Prostate Cancer

(2018) Weerachai Jaratlerdsiri et al.   CANCER RESEARCH

Pan-cancer deconvolution of tumour composition using DNA methylation

(2018) Ankur Chakravarthy et al.   Nature Communications

Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy

(2017) Jeffrey J. Tosoian et al.   EUROPEAN UROLOGY

An atlas of human long non-coding RNAs with accurate 5′ ends

(2017) Chung-Chau Hon et al.   NATURE

Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy

(2017) Teresa Davoli et al.   SCIENCE

Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations

(2017) Franklin W. Huang et al.   Cancer Discovery

Mutational Landscape of Aggressive Prostate Tumors in African American Men

(2016) Karla J. Lindquist et al.   CANCER RESEARCH

Systems analysis of the prostate transcriptome in African–American men compared with European–American men

(2016) Gary Hardiman et al.   PHARMACOGENOMICS

The Molecular Taxonomy of Primary Prostate Cancer

(2015) Adam Abeshouse et al.   CELL

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men

(2015) Gyorgy Petrovics et al.   EBioMedicine

Genomic Profiling of Prostate Cancers from African American Men

(2015) Patricia Castro et al.   NEOPLASIA

Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays

(2014) Martin J. Aryee et al.   BIOINFORMATICS

Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men

(2014) F. Khani et al.   CLINICAL CANCER RESEARCH

Copy number alteration burden predicts prostate cancer relapse

(2014) H. Hieronymus et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data

(2014) Julia L. Williams et al.   Cancer Genetics

Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men

(2013) I. J. Powell et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion

(2013) B Gumuskaya et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

(2011) Brett S. Carver et al.   CANCER CELL

Gene expression pathways of high grade localized prostate cancer

(2011) Ashley E. Ross et al.   PROSTATE

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

(2010) Tarek A. Bismar et al.   BJU INTERNATIONAL

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Copy number and gene expression differences between African American and Caucasian American prostate cancer

(2010) Amy E Rose et al.   Journal of Translational Medicine

TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients

(2010) Cristina Magi-Galluzzi et al.   PROSTATE

Diversity of Human Copy Number Variation and Multicopy Genes

(2010) Peter H. Sudmant et al.   SCIENCE

CCL3L1 and HIV/AIDS susceptibility

(2009) Tanmoy Bhattacharya et al.   NATURE MEDICINE

Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men

(2008) T. A. Wallace et al.   CANCER RESEARCH

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

(2008) Maisa Yoshimoto et al.   MODERN PATHOLOGY